In addition, SETD3 regulates the expression of multiple breast-cancer-associated genes, such as ACTB, FBXW7, Fascin, eNOS, and MMP-2, which suggests it as a promising biomarker for breast cancer prognosis (17). This evidence concerns the gene ACTB and breast carcinoma.